These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1430244)

  • 21. False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents.
    Tarkowski A; Bjursten LM; Nilsson LA; Nygren H
    J Immunol Methods; 1983 Mar; 58(1-2):171-82. PubMed ID: 6601157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity.
    Hunt Gerardo S; Persselin JE; Stevens RH
    Clin Exp Immunol; 1990 Aug; 81(2):293-300. PubMed ID: 1696866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs.
    Hennig C; Rink L; Fagin U; Jabs WJ; Kirchner H
    J Immunol Methods; 2000 Feb; 235(1-2):71-80. PubMed ID: 10675759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of primate antibody responses to administered murine monoclonal immunoglobulin.
    Milenic DE; Detrick B; Reynolds JC; Colcher D
    Int J Biol Markers; 1990; 5(4):177-87. PubMed ID: 2093733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of antibodies to the F(ab')2 fragment of human IgG.
    Heimer R; Wolfe LD; Abruzzo JL
    Arthritis Rheum; 1985 May; 28(5):562-8. PubMed ID: 3873943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion of a non-immunoglobulin binding protein in two-site ELISA for quantification of human serum proteins without interference by heterophilic serum antibodies.
    Andersson M; Rönnmark J; Areström I; Nygren PA; Ahlborg N
    J Immunol Methods; 2003 Dec; 283(1-2):225-34. PubMed ID: 14659914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.
    Courtenay-Luck NS; Epenetos AA; Moore R; Larche M; Pectasides D; Dhokia B; Ritter MA
    Cancer Res; 1986 Dec; 46(12 Pt 1):6489-93. PubMed ID: 2430699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment.
    Clark JI; Alpaugh RK; von Mehren M; Schultz J; Gralow JR; Cheever MA; Ring DB; Weiner LM
    Cancer Immunol Immunother; 1997 Jul; 44(5):265-72. PubMed ID: 9247561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.
    Reinsberg J; Wagner U; Krebs D
    Arch Gynecol Obstet; 1994; 255(1):9-18. PubMed ID: 8042882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatography.
    Koper NP; Thomas CM; Massuger LF; Segers MF; Olthaar AJ; Verbeek AL
    Clin Chem Lab Med; 1998 Jan; 36(1):23-8. PubMed ID: 9594082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of T-cell immunity in humans with preexisting anti-mouse immunoglobulin reactivity.
    Conry RM; Khazaeli MB; LoBuglio AF
    Cancer Res; 1992 Dec; 52(24):6979-82. PubMed ID: 1458491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors.
    Greenman J; Tutt AL; George AJ; Pulford KA; Stevenson GT; Glennie MJ
    Mol Immunol; 1991 Nov; 28(11):1243-54. PubMed ID: 1835758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference by human anti-mouse antibody in two-site immunoassays.
    Kricka LJ; Schmerfeld-Pruss D; Senior M; Goodman DB; Kaladas P
    Clin Chem; 1990 Jun; 36(6):892-4. PubMed ID: 2192822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy.
    Primus FJ; Kelley EA; Hansen HJ; Goldenberg DM
    Clin Chem; 1988 Feb; 34(2):261-4. PubMed ID: 3277745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies against human anti-F(ab')2 antibodies react with light chain epitopes.
    Silvestris F; Rots N; Yancey WB; Malone C; Searles R; Solomon A; Dammacco F; Williams RC
    Clin Immunol Immunopathol; 1991 Apr; 59(1):139-55. PubMed ID: 1708314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies.
    Warren DJ; Bjerner J; Paus E; Børmer OP; Nustad K
    Clin Chem; 2005 May; 51(5):830-8. PubMed ID: 15718486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal analysis of a human antimouse antibody (HAMA) response.
    Thorpe SJ; Turner C; Heath A; Feavers I; Vatn I; Natvig JB; Thompson KM
    Scand J Immunol; 2003 Jan; 57(1):85-92. PubMed ID: 12542802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG anti-F(ab')2 antibodies from SLE patients react with immunodominant residues in kappa CDRs, but show reduced C kappa region reactivity.
    Williams RC; Malone CC; Roemer JH; Silvestris F; Solomon A
    Clin Immunol Immunopathol; 1995 Dec; 77(3):366-73. PubMed ID: 7586748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies.
    Nordling C; Holmdahl R; Klareskog L
    J Immunol; 1991 Jun; 146(12):4258-63. PubMed ID: 1710245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.
    Horneff G; Winkler T; Kalden JR; Emmrich F; Burmester GR
    Clin Immunol Immunopathol; 1991 Apr; 59(1):89-103. PubMed ID: 2019013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.